GW Pharmaceuticals plc Announces US Patent Allowance for Use of Cannabidivarin in Treating Epilepsy
April 27, 2015 at 07:03 AM EDT
GW Pharmaceuticals plc (AIM:GWP) (Nasdaq: GWPH) ("GW") announced today that the United States Patent and Trademark Office (USPTO) has ...